AbbVie Inc. (4AB.DE) XETRA
182.75
-0.15(-0.08%)
Currency In EUR
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 409.2B |
| Enterprise Value | 473.04B |
| P/E Ratio | 105.01 |
| PEG Ratio | -7.96 |
| Price/Sales Ratio | 6.06 |
| Price/Book Ratio | 13.9 |
| Enterprise/Revenue | 7.07 |
| Enterprise/EBITDA | 26.24 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.06 |
| Operating Margin | 0.28 |
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.68 |
Income Statement
| Revenue | 61.16B |
| Revenue/Share | 35.41 |
| Gross Profit | 42.96B |
| EBITDA | 17.63B |
| Net Income | 4.23B |
| Diluted EPS | 2.36 |
Balance Sheet
| Total Cash | 9.36B |
| Total Cash/Share | 5.29 |
| Total Debt | 72.58B |
| Total Debt/Equity | 2.65 |
| Current Ratio | 0.8 |
| Book Value Per Share | 15.5 |
Price History
| 52-Week Change | 12.53 |
| 52-Week High | 207 |
| 52-Week Low | 155.2 |
| Moving Average 50 Days | 179.09 |
| Moving Average 200 Days | 188.41 |
Statistics
| Average Volume | 512 |
| Shares Outstanding | 1.77B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 6.74 |
| Trailing Annual Dividend Yield | 3.13 |
| Payout Ratio | 3.25 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
